MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, NXGL made $2,934,000 in revenue. -$653,000 in net income. Net profit margin of -22.26%.

Income Overview

Revenue
$2,934,000
Net Income
-$653,000
Net Profit Margin
-22.26%
EPS
-$0.08
Unit: Dollar
Revenue Breakdown
    • Nex Gel Rx Inc
    • CGConverting And Packaging LLC

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Revenues, net
2,934,000 2,884,000 2,806,000 2,154,000
Cost of revenues
1,691,000 1,626,000 1,618,000 1,626,000
Gross profit
1,243,000 1,258,000 1,188,000 528,000
Research and development
7,000 0 1,000 666.667
Selling, general and administrative
1,961,000 1,894,000 1,964,000 1,383,000
Other expense
-37,000 39,000 1,000
Total operating expenses
1,968,000 1,894,000 1,965,000 1,384,000
Gain on investments
-0 -17,000
Loss from operations
-725,000 -636,000 -777,000 -856,000
Interest expense, net
10,000 -21,000 -21,000 15,500
Change in fair value of warrant liability, net of warrant modification expense
----7,000
Loss on sale of assets
-0 --
Other income
59,000 41,000 68,000 26,500
Change in fair value of contingent consideration
---4,500
Changes in fair value of warrant liability and warrant modification expense
---91,000 -
Changes in fair value of warrant liability
9,000 13,000 --
Total other income (expense), net
78,000 -4,000 99,000 -9,000
Loss before income taxes
-647,000 -640,000 -678,000 -865,000
Income tax expense
-0 --
Net loss
-647,000 -640,000 -678,000 -865,000
Less income (loss) attributable to non-controlling interest in joint venture
6,000 25,000 34,000 -13,500
Net loss attributable to nexgel stockholders
-653,000 -665,000 -712,000 -851,500
Net loss per common share - basic
-0.08 -0.09 -0.09 -0.125
Net loss per common share - diluted
-0.08 -0.09 -0.09 -0.125
Weighted average shares used in computing net loss per common share diluted
7,971,299 7,654,348 7,645,311 -3,156,244
Weighted average shares used in computing net loss per common share - basic
7,971,299 7,654,348 7,645,311 -3,156,244
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to nexgel...-$653,000 Less income (loss)attributable to...$6,000 Net loss-$647,000 Changes in fair value ofwarrant liability$9,000 Other income$59,000 Interest expense, net$10,000 CGConverting And PackagingLLC$706,000 Nex Gel Rx Inc$2,228,000 Loss before incometaxes-$647,000 Total other income(expense), net$78,000 Revenues, net$2,934,000 Loss from operations-$725,000 Gross profit$1,243,000 Cost of revenues$1,691,000 Total operatingexpenses$1,968,000 Selling, general andadministrative$1,961,000 Research and development$7,000

NEXGEL, INC. (NXGL)

NEXGEL, INC. (NXGL)